Cargando…
GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
PURPOSE: Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune system upon irradiation has been identified as a key precipitating event of OM. To better understand OM’s pathogenesis, we studied...
Autores principales: | Pulsipher, Abigail, Savage, Justin R., Kennedy, Thomas P., Gupta, Kavita, Cuiffo, Benjamin G., Sonis, Stephen T., Lee, Won Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997003/ https://www.ncbi.nlm.nih.gov/pubmed/33770116 http://dx.doi.org/10.1371/journal.pone.0249343 |
Ejemplares similares
-
A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis
por: Savage, Justin R., et al.
Publicado: (2016) -
The Chicken or the Egg? Changes in Oral Microbiota as Cause or Consequence of Mucositis During Radiation Therapy
por: Sonis, Stephen T.
Publicado: (2017) -
Effects of GM-1111 on hyperoxia-impaired bacterial clearance and acute lung injury in ventilator-associated pneumonia
por: Stewart, Maleka, et al.
Publicado: (2022) -
Precision medicine for risk prediction of oral complications of cancer therapy–The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck
por: Sonis, Stephen T.
Publicado: (2022) -
A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment
por: Sonis, Stephen T.
Publicado: (2021)